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Abstract
Background: Screening and early diagnosis has been shown to reduce the morbidity and mortality associated
with certain conditions such as cervical cancer. The role of general practitioners in promoting primary prevention
of diseases is particularly important given that they have frequent contact with a large proportion of the
population. This study assessed the extent to which general practitioners documented recommended preventive
screening interventions among eligible patients.
Methods: We used a retrospective chart audit to assess patient visits to primary care clinics in Calgary, Canada
from 2002-2004. We included fee for service physicians who practiced ≥ 2 days per week at their current location
and excluded those whose primary practice was at walk-in clinics, community health centers, hospitals or
emergency rooms. We included charts of patients who during the study period were age 35 years or older and
had at least 2 visits to a clinic. We randomly selected and reviewed charts (N = 600) from 12 primary care clinics
and abstracted information on 6 conditions recommended for preventive screening. Opportunities for preventive
screening were determined based on recommendations of the Canadian Task Force on Preventive Health Care, the
American College of Physicians, and the Canadian Cancer Society. Our main outcome measures included cancer
screening (mammography and pap smears), immunization (influenza and pneumococcal), and risk factor
assessment (cholesterol measurement and smoking cessation consultation).
Results: Patient visits to GP clinics present opportunities for preventive screening. However, we found that
documentation of interventions was low, ranging from 40.3% (cholesterol measurement) to 0.9% (pneumococcal
vaccination) within 1 year, and from 67.4% to 1.8% within the prior 3 years.
Conclusions: Documentation of preventive screening interventions by general practitioners was relatively low
compared to the number of patients eligible for preventive screening. Some physicians opt to screen for PSA and
DRE which is not recommended by the Canadian Task Force on Preventive HealthCare.
Background
Screening and early diagnosis has been shown to reduce
the morbidity and mortality associated with certain con-
ditions such as cervical cancer, where screening com-
bined with treatment can reduce cervical cancer
mortality by about 70% [1,2]. Measuring the extent to
which preventive care is actually undertaken in general
practice settings is difficult. Some studies have used
recommended screening recorded in medical or
administrative records of patients to ascertain completed
screening [3,4]. In cancer screening for example, receiv-
ing a recommendation from a healthcare provider is an
important determinant of adherence to cancer screening
guidelines [5-7]. However, missed opportunities for pre-
ventive screening have been documented in clinical
encounters [3,5,7].
General practitioners (GPs) have frequent contact with
a large proportion of the population and could play a
particularly important role in promoting primary pre-
vention by recommending screening tests. In the fee-
for-services healthcare system, GPs in Canada are paid
by volume of patients, without consideration of quality
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becomes crucial in assessing patient needs and providing
treatment. With aging population, chronic diseases
become prevalent and consume the most of GPs’ avail-
able time [8]. Thus, time constrains limit the ability of
physicians to comply with preventive services recom-
mendations [9]. Given the constrains pose by time, and
the relatively low rate of physician adoption of some
clinical guidelines in general [10-12], the extent to
which GPs document recommended screening is not
well understood. The purpose of this study was to assess
the extent to which GPs document recommended pre-
ventive screening interventions among eligible patients.
Such knowledge can help developers of guidelines and
health decision makers to design effective ways to
improve preventive screening.
Methods
Design and Setting
This was a retrospective case audit of patients’ medical
records at GP clinics in Calgary. We choose Calgary
urban over rural because of the heterogeneity in GP
practice and convenience of data collection. Using lists
of GPs obtained from the Alberta provincial licensing
physician directories in Canada; we randomly selected
and approached 20 practices with verified phone num-
bers, in Calgary, to determine their eligibility and to
invite them (offering incentives) to participate in the
study.
We included fee for service PGs who practiced > 2
days per week at their current location from 2002-2004
and excluded PGs whose primary practice was at walk-
in clinics, community health centers, hospitals or emer-
gency rooms. These were excluded because most of
their patients do not see them regularly. Given that
recommended annual medical examinations are routi-
nely conducted by GPs, this exclusion criteria was
aimed to include physicians with consistent opportu-
nities to recommend screening for certain conditions.
Ethics approval was obtained from the University of Cal-
gary Conjoint Health Research Ethics Board. Physicians
who agreed to participate completed a consent form.
Chart data collection and determining patient eligibility
We randomly selected 50 charts from each of 12 eligible
primary care clinics in the city of Calgary for patients
who: 1)were age 35 years or older, 2)had at least 2 visits
to a GP clinic between 2002-2004. This gave a sample
of 600 patients (i.e. 550 paper charts from 11 clinics and
50 electronic medical records from 1 clinic). A sample
size of 400 or more would have sufficient power to
determine the frequency of preventive care within 5% of
the true value with a precision of 95%.
Two nurses underwent training in the data abstraction
process by reviewing selected charts individually, and
subsequently together to reach consensus were discre-
pancies existed. We developed a data abstraction form
(table 1) to record information under three sections
(medical history, blood pressure reading, and GP recom-
mendations). Using the data abstraction form, reviewers
independently abstracted information from charts and
electronic medical records, including demographic data,
and recommendations for cancer screening (mammogra-
phy and pap smears), immunization (influenza and
pneumococcal), and risk factor assessment (cholesterol
measurement and smoking cessation) in the prior three
years (i.e. 2002-2004).
Eligible patients for each of 6 conditions were deter-
mined based on the recommendations of the Canadian
Task Force on the periodic Health Examination (now
the Canadian Task Force on Preventive Health Care-
CTFPHC) [13], the American College of Physicians [14],
and the Canadian Cancer Society [15]. Given that the
CTFPHC recommends against performing the PSA and
DRE for asymptomatic men, we extracted data to assess
the ‘likely inappropriate’ use of the PSA and DRE. In
this study, we used only data from the ‘GP recommen-
dation’ section of the abstraction form. An intervention
was considered documented if it was recorded in the
medical record the actual date that the intervention was
completed, or the date it was recommended by the GP.
With proper documentation, and the absence of missed
opportunities for preventive screening, we would expect
documented interventions to properly reflect screening
rates. However, it is worth noting that recording rates of
recorded screening over a 1 and 3 year period is some
what blunt given the different frequencies for which
screening is recommended (some only 3 yearly-table 2).
Table 1 Data extraction form: GP recommendations
section
GP Recommendation Date Recommended Date Last done
(D/M/Y)
27) Mammogram Yes No Yes No
28) Pap Smear Yes No Yes No
29) PSA Yes No Yes No
30) Rectal Exam Yes No Yes No
31) Cholesterol Yes No Yes No
32) Influenza Vaccine Yes No Yes No
33) Pneumococcal
Vaccine
Yes No Yes No
34) Smoker No
N/R Yes Cessation
discussed
Yes No
35) Has had
hysterectomy
N/
A
No Yes
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frequency of preventive care was influenced by cluster-
ing at the level of GP clinic. The intra-cluster correla-
tion coefficient (ICC = 0.1) was calculated from an
ANOVA as follows:
ICC r    MSB MSW MSB k 1  MSW      /
Where,
MSB is the mean square between practices
MSW is the mean square within practices
k is the average number in each practice (50)
Descriptive statistics were used for demographic vari-
ables and to compute the proportion of interventions
documented for each condition, and documented inap-
propriate screening for PSA and DRE.
Results
We randomly selected and reviewed 600 charts (550
paper and 50 electronic records) from 12 GP clinics to
determine patient eligibility for preventive screening and
to assess documentation of preventive screening inter-
ventions for all 6 conditions considered. Overall, 67% of
the 600 charts belonged to female patients. The mean
age of patients was 54 years, ranging from 31.6 to 98.2
years. Among 12 clinics sampled, and for all eligible
patients, we found that actual preventive screens
documented ranged from 40.3% (cholesterol measure-
ment) to 0.9% (pneumococcal vaccination) within 1
year, and from 67.4% to 1.8% within the prior 3 years.
For the prior 3 years, and for all 6 conditions, this
represents on average 29.5% of preventive screening
opportunities that were documented (supposedly
addressed by GPs) compared to 70.5% on average that
remained undocumented (supposedly unaddressed or
missed opportunities). Likewise, documented ‘inap-
propriate screening’ ranged from 7.5% within 1 year to
33.0% within the prior 3 years for PSA and from 18.9%
to 44.3% for DRE (table 2).
Discussion
We found that patients visiting GP clinics present sev-
eral opportunities for preventive screening; however,
actual documentation of the interventions remained low
(29.5% on average in 3 years). Amongst eligible patients,
we found much variation in rates of implementation
between conditions (For example, 40% screening for
cholesterol compared to 0.9% for pneumocaccal vaccina-
tion in one year). This apparent disparity in implemen-
tation may be attributed to the fact that the available
information on patient medical history, blood pressure
readings, most likely influenced GP decisions on recom-
mending screening for cholesterol over other conditions.
However, this was not independently verified in our
Table 2 Number of opportunities for intervention identified and documented among patients presenting at GP clinics
(N = 600).
Intervention Criteria for determining patient
eligibility*
Patients eligible
for intervention in
2004
Documented need for
intervention in 1 year
(2004)
Documented need for
intervention in prior 3 years
(2002–2004)
Mammography for
breast cancer
Biannual screening –for women aged 50
– 69 years
142 40(28.2%) 61(43.0%)
Papanicolaou smear for
cervical cancer
Screen sexually active women at least
every 3 years
†
399 59(14.8%) 99(24.8%)
Cholesterol
measurement
Patients over 30 years of age, who either
smoke, have hypertension, or diabetes
mellitus.
233 94(40.3%) 157(67.4%)
Influenza vaccination Patients over 65 years of age 114 17(14.9%) 35(30.7%)
Pneumococcal
vaccination
Vaccination every 6 years of selected
high risk populations
Patients over 65 years of age
114 1(0.9%) 2(1.8%)
Smoking cessation Advise smokers to quit or refer to
smoking cessation counseling programs
99 3(3.0%) 19(9.2%)
‡Documented Inappropriate screening for PSA and DRE
Prostate specific antigen
test for prostate cancer
(PSA)
Men over 50 years of age (not required) 106 8(7.5%) 35(33.0%)
Digital rectal
examination (DRE) for
prostate cancer
Annual examination for men over 50
years of age (not required)
106 20(18.9%) 47(44.3%)
*Criteria used to identify opportunities for preventive intervention based on recommendations of the Canadian Task Force on the periodic Health Examination
[6], the American College of Physicians [7] and the Canadian Cancer Society [8].
†Sexual activity not defined – all women considered
‡The Canadian Task Force recommends that PSA and DRE not be performed
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this study belonged to females, one would have expected
that GPs have opportunities to recommend screening
for Pap smears given that most females were eligible.
However, the relatively low rates observed suggest cer-
tain factors including doctor gender, may have had an
influence on the doctor offering the intervention, or on
uptake as women tend to select women for these tests.
Due to the small sample of participating clinics (12), we
did not analyze GP gender matching factors; nor did we
record the gender of GPs.
The high number of undocumented interventions is of
concern and raises questions about implementation of
preventive screening recommendations by GPs. Our
results are similar to that of another study [11], where
compliance with recommendations remains low. A
study of Ontario physicians found that only a low pro-
portion of physicians adhere to breast cancer screening
recommendations, and the proportion was even lower
among physicians in cities [16]. In Calgary, missed
opportunities for preventive screening have also been
demonstrated in general internal medicine. In this set-
ting the digital rectal examination for prostate cancer
and cholesterol measurement were addressed most com-
monly, while papanicolaou smear for cervical cancer and
pneumococcal vaccination were addressed less com-
monly [3].
The reasons for low rates of preventive screening
practices are likely multi-factorial. In the case of PSA
and DRE for example, low rates of documented screen-
ing are understandable given that both procedures are
not supposed to be performed; thus the documented
rates for PSA and DRE observed in our study are ‘inap-
propriate’ according to CTFPHC. We reviewed docu-
mented need for pneumoccal vaccination in prior 3
years (1.8%) which is 3 years short of the guideline
recommended vaccination every 6 years of selected high
risk population’s of patients over 65 years of age. Even if
this rate were doubled to 4% as expected over 6 years,
this rate would still be low given the proportion of
patients eligible for vaccination.
Several studies [16-18] have documented numerous
barriers (patient, physician, social, and practice charac-
teristics) to adoption of preventive guidelines. Strategies
to promote preventive health by GPs include informa-
tion transfer, learning through social influence, feedback,
reminders, organizational reminders, financial incentives,
and regulatory interventions [19-23]. Multifaceted inter-
ventions (combination of information transfer and learn-
ing through social change or management support) have
been shown to be more effective than single interven-
tions (using information transfer) [20,22,23]. Studies
have shown that alternative payment approaches with
bonuses for targeted preventive care [24] or incentives
that elevate the revenue of GPs [25] may lead to an
increase in preventive care interventions to eligible
patients.
This study was limited by methodological issues inher-
ent in undertaking a retrospective chart audit. GPs may
recommend specific interventions but fail to document
them. This was missed in our study. As a consequence,
there is a possible underestimation of proportions due
to the fact that advice on preventive activities or the
activities themselves may have been provided but not
documented in the charts. This is likely the case for
topics such as smoking which do not require a specific
intervention besides advice for smoking cessation.
Another important limitation is that we did not explore
reasons for the low rates of interventions documented.
A likely reason is that GPs may have known (through
patient GP conversations) that the patient had already
had the preventive service provided in another service
therefore not offered it. In addition, physician gender
has been shown to improve screening for certain condi-
tions including pap testing [26], however we did not
perform GP-gender analysis in this study. Finally, we
studied 12 primary care clinics in Calgary urban and
were uncertain about the situation in rural and other
geographic areas. Thus our findings may not be general-
ized beyond Calgary.
Conclusion
Amongst eligible patients, documentation of preventive
screening interventions was generally low. This has
negative implications on preventive care, and might
increase the burden of preventable chronic conditions
and higher health care costs on the population and pub-
lic in general. Improving preventive screening by GPs
would require a much better investigation of the reasons
for the low rates of recommending screening for eligible
patients, GP practice setting, knowledge of guidelines,
perceptions on guidelines, available incentives, among
others. Our findings indicate the extent to which GPs
document preventive screening interventions and do not
accurately reflect adherence to recommended guidelines,
thus, the results should be interpreted with caution.
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